Efalizumab-induced lupus-like syndrome

Acta Dermato-Venereologica

Volumn 88, Issue 3, 2008, Pages 270-271

  Durox, Hélene ^a   Sparsa, Agnès ^a   Loustaud Ratti, Véronique ^a   Prey, Sorilla ^a   Gondran, Guillaume ^a   Manea, Petrus ^a   Vidal, Elisabeth ^a   Bedane, Christophe ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; COLECALCIFEROL DERIVATIVE; CORTICOSTEROID; CYCLOSPORIN; EFALIZUMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PSORALEN; RETINOID; STEROID;

ABDOMINAL PAIN; ADULT; ARTHRALGIA; ASTHENIA; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CASE REPORT; CHOLECYSTECTOMY; CHOLESTATIC HEPATITIS; CYTOLYTIC HEPATITIS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; ENTHESITIS; FEMALE; GAMMOPATHY; HISTORY; HUMAN; LETTER; LIVER BIOPSY; LUPUS LIKE SYNDROME; PAIN; PERICARDITIS; PRIORITY JOURNAL; PSORIASIS; RECURRENT DISEASE; ULTRAVIOLET A RADIATION;

ALANINE TRANSAMINASE; ANTIBODIES, MONOCLONAL; ASPARTATE AMINOTRANSFERASES; DERMATOLOGIC AGENTS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PSORIASIS; SYNDROME;

EID: 44349151955     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0393     Document Type: Letter

References (14)

1. Jullien D. Raptiva® (efalizumab): un nouveau traitement pour le psoriasis. Nouv Dermatol 2006; 25: 264-272.
2. Berthelot C, Cather J, Jones D, Duvic M. Atypical CD8+ cutaneous T-cell lymphoma after immunomodulatory therapy. Clin Lymphoma Myeloma 2006; 6: 329-332.
3. Bentley D, Graves J, Smith D, Heffernan MP. Efalizumab-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 2006; 54: 242-243.
4. Rubin RL. Drug-induced lupus. Toxicology 2005; 209: 135-147.
5. Klapman JB, Ene-Stroescu D, Becker MA, Hanauer SB. A lupus-like syndrome associated with infliximab therapy. Inflamm Bowel Dis 2003; 9: 176-178.
6. Carlson E, Rothfield N. Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis. Arthritis Rheum 2003; 48: 1165-1166.
7. Graziadei IW, Obermoser GE, Sepp NT, Erhart KH, Vogel W. Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis. Lupus 2003; 12: 409-412.
8. Clayton T, Ogden S, Googfield M. Treatment of refractory subacute cutaneous lupus erythematosus with efalizumab. J Am Acad Dermatol 2006; 54: 892-895.
9. Usmani N, Googfield M. Efalizumab in the treatment of discoid lupus erythematous. Arch Dermatol 2007; 143: 873-877.
10. Aringer M, Graninger WB, Steiner G, Smolen JS. Safety and efficacy of tumour necrosis factor alpha blockade in systemic lupus erythematous: an open-label study. Arthritis Rheum 2004; 50: 3161-3169.
11. De Bandt M, Sibilia J, Le Loët X, Prouzeau S, Fautrel B, Marcelli C, et al. Systemic lupus erythematous induced by anti-tumour necrosis factor alpha therapy: a french national survey. Arthritis Res Ther 2005; 7: 545-551.
12. Sparsa A. Etanercept. Ann Dermatol Venereol 2005; 132: 861-876.
13. Ferraccioli GF, Assaloni R, Perin A. Drug-induced systemic lupus erythematosus and TNF alpha blockers. Lancet 2002; 360: 645.
14. Dereure O, Guillot B, Jorgensen C, Cohen JD, Combes B, Guilhou JJ. Psoriatic lesions induced by anti-tumour necrosis factor-α treatment: two cases. Br J Dermatol 2004; 150: 506-525.